Gothamist

A non-profit newsroom, powered by WNYC.

Gothamist

WNYC Listen Live

Donate

 

 

News

Ex-Beth Israel Pharmacy Director Allegedly Stole $5.6 Million In Oxycodone


By

Rebecca Fishbein

Published Jul 8, 2014

Modified Jul 8, 2014


Share

FacebookTwitterRedditEmail


Never miss a story

 Email address

By submitting your information, you're agreeing to receive communications from New York Public Radio in accordance with our Terms .

 

Pete.Mac's flickr


By

Rebecca Fishbein

Published Jul 8, 2014

Modified Jul 8, 2014


Share

FacebookTwitterRedditEmail


We rely on your support to make local news available to all

Make your contribution now and help Gothamist thrive in 2026. Donate today

Gothamist is funded by sponsors and member donations

A former pharmacy director at a prominent New York hospital was arrested and indicted on drug charges this week after authorities discovered he had allegedly stolen $5.6 million worth of oxycodone pills.

Anthony D'Alessandro, who ran Beth Israel Medical Center's pharmacy for 14 years, was arrested at his Staten Island home this morning and has been charged with drug trafficking, criminal drug possession and grand larceny. According to the city's Special Narcotics Prosecutor, D'Alessandro stole nearly 200,000 pills from the hospital between January 2009 and April 2014. He allegedly used his position to access the narcotics vault, made false entries in the hospital's inventory system and even filled out fraudulent prescriptions for his wife, ultimately obtaining a whopping 193,376 pills worth approximately $5.6 million on the black market.

Investigators say D'Alessandro's painkiller pilfering was caught by hospital administrators after Beth Israel's parent company merged with Mount Sinai Medical Center. He was suspended and then fired on April 29, 2014. "This case underscores the vigilance required when addictive medication with a high resale value is readily available—even to licensed professionals and trusted employees," Special Narcotics Prosecutor Bridget Brennan said in a statement today. According to a statement from Mount Sinai spokesperson Sid Dinsay:

When an anonymous complaint was received by the new administration at Mount Sinai Beth Israel, Mount Sinai immediately conducted a comprehensive internal investigation and brought the results of our extensive investigation to the appropriate authorities. The individual was promptly suspended and then terminated. The administration of the Mount Sinai Health System and its hospitals have zero tolerance for theft and illegal activities and have been working closely with the district attorney's office throughout its investigation to assist in the prosecution.

Tagged

anthony d'alessandro

oxycodone

painkillers

original


Rebecca Fishbein

Read more

Gothamist is funded by sponsors and member donations


Gothamist is funded by sponsors and member donations


MORE news

Man shot by ICE in NYC still has bullet lodged in neck, attorneys say

Oscar Belgal, a 28-year-old immigrant from the Dominican Republic, was in solitary confinement at the Metropolitan Detention Center in Sunset Park on Monday.

By

Liam Quigley

Published Oct 12, 2026 at 11:37 a.m. ET


NY measles spread prompts 'disaster' emergency. It didn't have to be this way, health commissioner says.

The state health commissioner says the disease outbreak is wholly preventable.

By

Elizabeth Shwe

News

NY measles spread prompts 'disaster' emergency. It didn't have to be this way, health commissioner says.

The state health commissioner says the disease outbreak is wholly preventable.

By

Elizabeth Shwe


NYC wants to move deliveries onto the waterways. It's starting with a 55-year-old boat.

By

Liam Quigley

Inside the luxury Greenpoint high-rise powered by a rumbling generator for over a month

By

David Brand

Mayor Mamdani orders review of NYPD use of force policies

By

Michael Sol Warren


Never miss a story

Catch up on the most important headlines with a roundup of essential NYC stories, delivered to your inbox daily.

Sign upEmail address

By submitting your information, you're agreeing to receive communications from New York Public Radio in accordance with our Terms .